- In January 2025, Philips introduces a new pediatric nasal mask designed to improve the comfort and care of the smallest patients requiring respiratory support. This innovative mask provides better fit, stability, and skin protection for infants and young children undergoing CPAP therapy. The mask’s flexible design adapts to different facial contours, reducing pressure points and improving overall treatment compliance. By ensuring more effective treatment with fewer disruptions, it promises to enhance both the comfort and safety of pediatric patients, ultimately leading to improved respiratory outcomes for young children with sleep apnea and other respiratory conditions
- In January 2025, Intersurgical has launched its new nFlow CosyFit infant nasal CPAP range, designed to enhance respiratory support for neonates and infants. This innovative range offers a more comfortable and secure fit, improving treatment compliance for infants requiring CPAP therapy. The CosyFit nasal prongs are soft and gentle on the skin, reducing irritation and ensuring better patient comfort during respiratory treatments. By providing a precise and effective solution for neonatal respiratory care, the nFlow CosyFit range aims to improve outcomes for premature infants and those with respiratory distress, contributing to safer and more effective respiratory support in critical care settings
- In November 2024, Fisher & Paykel Healthcare introduced the F&P Nova Micro in the United States, a next-generation infant nasal mask designed for neonatal respiratory care. The F&P Nova Micro is a compact and lightweight mask engineered to deliver non-invasive ventilation with improved comfort and stability for infants, particularly in neonatal intensive care units (NICUs). Its innovative design reduces the risk of skin irritation while ensuring a secure fit, enhancing both safety and effectiveness in delivering oxygen or positive pressure. The mask's advanced features aim to improve patient outcomes by providing better respiratory support for premature and critically ill infants. This launch reflects Fisher & Paykel Healthcare commitment to advancing neonatal care and improving respiratory health outcomes for newborns
- In March 2020, AG Industries unveiled their new Pediatric Full-Face CPAP Mask, specifically designed to enhance comfort and effectiveness for young patients undergoing CPAP therapy for sleep-related breathing disorders. The mask features a child-friendly design, with soft, flexible materials that ensure a snug yet gentle fit, minimizing discomfort and improving compliance. The mask aims to provide a secure seal for young patients, ensuring optimal therapy while reducing air leaks. Its lightweight and adjustable features make it suitable for a wide range of pediatric patients, offering both comfort and reliability. By launching this innovative CPAP mask, AG Industries seeks to improve the quality of sleep therapy for children, ensuring better respiratory health and overall well-being
